Filters

ANKS4B Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

ANKS4B Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) size: 1.0 µg DNA 600

Supplier ABM LENTIVECTORS
Price 600
Size 1.0 µg DNA
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
DNA lentivector for transduction information GENTAUR suggests to use our ABM packaging mix LV003 of second generation virusses or the LV053, This DNA can alos be used for packaging into Lentiviral particles for high efficiency transduction and stably integrated expressions, Vectors with selection markers like kanamycin, our 3rd Generation Packaging mixture, pLenti lentiviral plasmids DNAs are stored in 10milliMolar Tris/HCI with 1mM EDTA at a pH of 8 at -25 C, puromycin or cumate are available, Lentiveral packaging plasmid DNA for non-viral plasmid transfection and direct use in plasmid expression
Properties Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine,  , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp
Gene targetANKS4B Lentiviral Vector (CMV) (pLenti-GIII-CMV)
Short nameANKS4B Lentiviral Vector ( ) (CMV) (pLenti-GIII-CMV)
TechniqueVectors
Species Humans, Human
Alternative name sapiens) (cytomegalovirus) (pLenti-GIII-cytomegalovirus), ANKS4B Lentiviral integrating Desoxyribonucleic acid sequence (H
Identity 26795
Gene ANKS4B
Long gene name ankyrin repeat and sterile alpha motif domain containing 4B
Synonyms FLJ38819 HARP
Locus 16p12, 2
Discovery year 2006-02-17
GenBank acession AK096138
Entrez gene record 257629
RefSeq identity NM_145865
Classification Ankyrin repeat domain containing Sterile alpha motif domain containing
Havana BLAST/BLAT OTTHUMG00000177371

Similar products

Subscribe to our Newsletter